Non-nutrient causes of low-grade, systemic inflammation: Support for a 'canary in the mineshaft' view of obesity in chronic disease

Obesity Reviews

Volumn 12, Issue 5, 2011, Pages 339-345

  Egger, G ^a,b   Dixon, J ^c  

^a SOUTHERN CROSS UNIVERSITY   (Australia)

^b Centre for Health Promotion and Research   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Canary; Inflammation; Mineshaft; Obesity

Indexed keywords

CARBON DIOXIDE;

AGE; AIR POLLUTION; ANXIETY; CAUSAL ATTRIBUTION; CHRONIC DISEASE; DEPRESSION; ENVIRONMENTAL FACTOR; HUMAN; INFLAMMATION; LIFESTYLE; LOWEST INCOME GROUP; OBESITY; PASSIVE SMOKING; REVIEW; RISK FACTOR; SLEEP PATTERN; SLEEP TIME; SMOKING; SOCIAL ASPECT; STRESS;

AIR POLLUTION; CHRONIC DISEASE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIFE STYLE; OBESITY; SMOKING; SOCIOECONOMIC FACTORS;

EID: 79954591721     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2010.00795.x     Document Type: Review

References (85)

1. Hotamisligil GS. Inflammation and metabolic disease. Nature 2006; 444: 860-867.
2. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007; 1265: S140-S146.
3. Egger G, Dixon J. Obesity and chronic disease: always offender, or often just accomplice? Br J Nutr 2009a; 102: 1238-1242.
4. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Heiss G. Inflammation markers predict increased weight gain in smoking quitters. Obes Res 2003; 11: 1339-1344.
5. Egger G, Swinburn B. An 'ecological' approach to the obesity pandemic. BMJ 1997; 315: 477-480.
6. Egger G, Dixon J. Should obesity be the main game? Or do we need an environmental makeover to combat the inflammatory and chronic disease epidemics? Obes Rev 2009b; 10: 237-249.
7. Egger G, Dixon J. Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev 2010; (in press).
8. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 2005; 78: 819-835.
9. Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 2006; 42: 105-117.
10. Brook RD. Cardiovascular effects of air pollution. Clin Sci (Lond) 2008; 115: 175-187.
11. Kaiser J. Epidemiology. Mounting evidence indicts fine particle pollution. Science 2005; 307: 1858-1861.
12. Pope CA, Burnett RT, Thurston GD. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004; 109: 71-77.
13. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, Sandstrom T, Blomber A, Newby DE. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med 2009; 6: 36-44.
14. Gomez-Mejiba SE, Zhai Z, Akram H, Pye QN, Hensley K, Kurien BT, Scofield RH, Ramirez DC. Inhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegeneration. Mutat Res 2009; 674: 62-72.
15. Chen JC, Schwartz J. Metabolic syndrome and inflammatory responses to long-term particulate air pollutants. Environ Health Perspect 2008; 116: 612-617.
16. Leaderer BP, Zagraniski RT, Berwick M, Stolwijk JA. Assessment of exposure to indoor air contaminants from combustion sources: methodology and application. Am J Epidemiol 1986; 124: 275-289.
17. Wargocki P, Sundell J, Bischof W, Brundrett G, Fangor PO, Gyntelberg F, Hanssen SO, Harrison P, Pickering A, Seppanen O, Woulters P. Ventilation and health in non-industrial indoor environments: report from a European multidisciplinary scientific consensus meeting (EUROVEN). Indoor Air 2002; 12: 113-128.
18. Panasevich S, Leander K, Rosenlund M, Ljungman P, Bellander T, de Faire U, Pershagen G, Nyberg F. Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med 2009; 66: 747-753.
19. Calderón-Garcidueñas L, Macías-Parra M, Hoffmann HJ, Valencia-Salazar G, Henríquez-Roldán C, Osnaya N, Monte OC, Barragán-Mejía G, Villarreal-Calderon R, Romero L, Granada-Macías M, Torres-Jardón R, Medina-Cortina H, Maronpot RR. Immunotoxicity and environment: immunodysregulation and systemic inflammation in children. Toxicol Pathol 2009; 37: 161-169.
20. Kelishadi R, Mirghaffari N, Poursafa P, Gidding SS. Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children. Atherosclerosis 2009; 203: 311-319.
21. Kampfrath T, Mikolaj MB, Cai Y, Ostrowski MC, Lu B, Parthasarathy S, Brook RD, Moffatt-Bruce SD, Chen LC, Rajagopalan S. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation 2009; 119: 538-546.
22. Nemmar A, Hoylaerts MF, Hoet PH, Nemery B. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett 2004; 149: 243-253.
23. Kelly FJ. Oxidative stress: its role in air pollution and adverse health effects. Occup Environ Med 2003; 60: 612-616.
24. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 168-175.
25. Forbes LJ, Patel MD, Rudnicka AR, Cook DG, Bush T, Stedman JR, Whincup PH, Strachan DP, Anderson HR. Chronic exposure to outdoor air pollution and markers of systemic inflammation. Epidemiology 2009; 20: 245-253.
26. Zappulla D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 2008; 31: 30-34.
27. Kimura D, Totapally BR, Raszynski A, Ramachandran C, Torbati D. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood. Crit Care Med 2008; 36: 2823-2827.
28. Abolhassani M, Guais A, Chaumet-Riffaud P, Sasco AJ, Schwartz L. Carbon dioxide inhalation causes pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol 2009; 296: 657-665.
29. Intergovernmental Panel on Climate Change. Climate change: Contribution of Working Group I to the Fourth Assessment Report of the Intergovernmental Panel on Climate Change, 2007. [WWW document]. URL (accessed 5 July 2010).
30. Viegi G, Simoni M, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L, Annesi-Maesano I. Indoor air pollution and airway disease. Int J Tuberc Lung Dis 2004; 8: 1401-1415.
31. Egger G. Dousing our inflammatory environment(s): is personal carbon trading an option for reducing obesity - and climate change? Obes Rev 2008; 9: 456-463.
32. Tapia Granados JA, Carpintero O. Dispelling the smoke: CO2 emissions and economic growth from a global perspective. Unpublished Paper, Michigan University, 2010.
33. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke. Nearly as large as smoking. Circulation 2005; 111: 2684-2698.
34. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Masoura C, Toutouzas P, Stefanadis C. Effect of exposure to second hand smoke on markers of inflammation: the ATTICA study. Am J Med 2004; 116: 145-150.
35. Nakata A, Tanigawa T, Araki S, Sakurai S, Iso H. Lymphocyte subpopulations among passive smokers. JAMA 2004; 291: 1699-1700.
36. European Commission. Tobacco or Health in the European Union - Past, Present and Future. The ASPECT Consortium 2004. Office for Official Publications of the European Communities: Luxembourg, 2004.
37. Raupach T, Schafer K, Konstantinides S, Andreas S. Second hand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J 2006; 27: 3-86.
38. Wilkinson RG, Marmot MG. Social Determinants of Health, 2nd edn. Oxford University Press: New York, 2006.
39. Dalstra JA, Kunst AE, Borrell C, Breeze E, Cambois E, Costa G, Geurts JJ, Lahelma E, Van Oyen H, Rasmussen NK, Regidor E, Spadea T, Mackenbach JP. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol 2005; 34: 316-326.
40. Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J, Montaye M, Amouyel P, Ferrières J, Ruidavets JB, Evans A, Bingham A, Ducimetière P; PRIME study group. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol 2005; 34: 268-275.
41. Sethi R, Puri A, Makhija A, Singhal A, Ahuja A, Mukerjee S, Dwivedi SK, Narain VS, Saran RK, Puri VK. 'Poor man's risk factor': correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome. Indian Heart J 2008; 60: 205-209.
42. Ramsay S, Lowe GD, Whincup PH, Rumley A, Morris RW, Wannamethee SG. Relationships of inflammatory and haemostatic markers with social class: results from a population-based study of older men. Atherosclerosis 2008; 197: 654-661.
43. Hong S, Nelesen RA, Krohn PL, Mills PJ, Dimsdale JE. The association of social status and blood pressure with markers of vascular inflammation. Psychosom Med 2006; 68: 517-523.
44. Gémes K, Ahnve S, Janszky I. Inflammation a possible link between economical stress and coronary heart disease. Eur J Epidemiol 2008; 23: 95-103.
45. Miller G, Chen E. Unfavorable socioeconomic conditions in early life presage expression of proinflammatory phenotype in adolescence. Psychosom Med 2007; 69: 402-409.
46. Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood. J Epidemiol Community Health 2008; 62: 484-491.
47. Marmot M. The Status Syndrome. Henry Holt and Co.: London, 2004.
48. Powell ND, Bailey MT, Mays JW, Stiner-Jones LM, Hanke ML, Padgett DA, Sheridan JF. Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion. Brain Behav Immun 2009; 23: 225-231.
49. Wilkinson R, Pickett K. The Spirit Level: Why More Equal Societies Almost Always Do Better. Penguin: London, 2009.
50. Elovainio M, Ferrie JE, Singh-Manoux A, Gimeno D, De Vogli R, Shipley M, Vahtera J, Brunner E, Marmot MG, Kivimäki M. Organizational justice and markers of inflammation: the Whitehall II study. Occup Environ Med 2010; 67: 78-83.
51. Franceschi C. Inflammaging as a major characteristic of old people; can it be prevented or cured? Nutr Rev 2007; 11: S173-S176.
52. Giunta B, Fernandez F, Nikolic WV, Obregon D, Rrapo E, Town T, Tan J. Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 2008; 11: 5-51.
53. Ho CT, Su CL, Chen MT, Liou YF, Lee SD, Chien KY, Kuo CH. Aging effects on glycemic control and inflammation for politicians in Taiwan. Chin J Physiol 2008; 51: 402-407.
54. Nakajima K, Yamaoka H, Morita K, Ebata M, Eguchi S, Muneyuki T, Munakata H. Elderly people with low body weight may have subtle low-grade inflammation. Obesity (Silver Spring) 2009; 17: 803-808.
55. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M; Health ABC Study. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009; 64: 1183-1189.
56. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008; 2: 133-138.
57. Van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59: 713-721.
58. Thorley AJ, Tetley TD. Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007; 2: 409-428.
59. van Eeden SF, Yeung A, Quinlam K, Hogg JC. Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 61-67.
60. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007; 131: 1557-1566.
61. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation part one. Circulation 2003; 108: 1917-1923.
62. Willemse BWM, Postma DS, Tiimes W, ten Hacken NHT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23: 464-467.
63. Halvorsen B, Lund Sagen E, Ueland T, Aukrust P, Tonstad S. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest 2007; 67: 604-611.
64. Komiya H, Mori Y, Yokose T, Tajima N. Smoking as a risk factor for visceral fat accumulation in Japanese men. Tohoku J Exp Med 2006; 208: 123-132.
65. Mizuno O, Okamoto K, Sawada M, Mimura M, Watanabe T, Morishita T. Obesity and smoking: relationship with waist circumference and obesity-related disorders in men undergoing a health screening. J Atheroscler Thromb 2005; 12: 199-204.
66. Patel SR, Zhu X, Storfer-Isser A, Mehra R, Jenny NS, Tracy R, Redline S. Sleep duration and biomarkers of inflammation. Sleep 2009; 32: 200-204.
67. Burgos I, Richter L, Klein T, Fiebich B, Feige B, Lieb K, Voderholzer U, Riemann D. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun 2006; 20: 246-253.
68. Trakada G, Chrousos G, Pejovic S, Vgontzas A. Sleep apnea and its association with the stress system, inflammation, insulin resistance and visceral obesity. Sleep Med Clin 2007; 2: 251-261.
69. Chaput J-P, Tremblay A. Does short sleep duration favor abdominal adiposity in children? Int J Pediatr Obes 2007; 2: 188-191.
70. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass. PLoS Med 2004; 1: e62.
71. Punjabi NM, Bearner BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007; 30: 29-34.
72. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006; 166: 1756-1762.
73. Opp MR. Cytokines and sleep. Sleep Med Rev 2005; 9: 355-364.
74. Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann NY Acad Sci 2006; 1083: 329-344.
75. Schmid SM, Hallschmid M, Jauch-Chara K, Bandorf N, Born J, Schultes B. Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counter regulatory response to hypoglycemia. J Clin Endocrinol Metab 2007; 92: 3044-3051.
76. Dement WC. The Promise of Sleep. Delacorte Press: New York, 1999.
77. Simpson N, Dinges DF. Sleep and inflammation. Nutr Rev 2007; 65: S244-S252.
78. Weissman G. The experimental pathology of stress: Hans Selye to Paris Hilton. FASEB J 2007; 21: 2635-2638.
79. Black PH. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 2003; 17: 350-364.
80. Kryou I, Chrounos GP, Tsigos C. Stress, visceral obesity and metabolic syndrome. Ann NY Acad Sci 2006; 1083: 77-110.
81. Hamer M, Gibson EL, Vuononvirtac R, Williamsa E, Steptoe A. Inflammatory and hemostatic responses to repeated mental stress: individual stability and habituation over time. Brain Behav Immun 2006; 20: 456-459.
82. Kulmatycki KM, Jamali F. Drug disease interactions: role of inflammatory mediators in depression and variability in antidepressant drug response. J Pharm Pharm Sci 2006; 9: 292-306.
83. Warne JP, Dallman MF. Stress, diet and abdominal obesity. Nature Med 2007; 13: 781-783.
84. von Känel R, Bellingrath S, Kudielka BM. Association between burnout and circulating levels of pro- and anti-inflammatory cytokines in schoolteachers. J Psychosom Res 2008; 65: 51-59.
85. Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 2010; 6: 345-352.